2009 annual financial data
GT Biopharma 2009 Net margin
Direct answer
Net margin was -4,679.17%.
Operating income was -1,156,000 USD and net income was -2,246,000 USD.
Operating cash flow was -937,000 USD.
Get free GT Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 48,000 USD
- Operating income
- -1,156,000 USD
- Net income
- -2,246,000 USD
- Operating cash flow
- -937,000 USD